These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 3773980)

  • 1. Susceptibility of clinical isolates of yeasts to anti-fungal agents.
    Hussain Qadri SM; Flournoy DJ; Qadri SG; Ramirez EG
    Mycopathologia; 1986 Sep; 95(3):183-7. PubMed ID: 3773980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of yeasts for fluconazole and itraconazole. Evaluation of a microdilution test.
    Nenoff P; Oswald U; Haustein UF
    Mycoses; 1999; 42(11-12):629-39. PubMed ID: 10680439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of the in vitro sensitivity of yeasts with the ATB-Fungus system].
    Martínez MM; Mendaza P; Daza RM; Sánchez G; Martín P; Martín JE; Portero F
    Rev Esp Quimioter; 1998 Sep; 11(3):251-3. PubMed ID: 9795312
    [No Abstract]   [Full Text] [Related]  

  • 4. [Isolation, identification and drug-resistance of nosocomial yeasts].
    Alegente G; Gonnelli A; Galgani P; Boggiano CA
    Ann Sclavo; 1982; 24(2):103-13. PubMed ID: 6763853
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of susceptibility to five antifungal agents of yeast cultures from burn patients.
    Still JM; Law EJ; Belcher KE; Spencer SA
    Burns; 1995 May; 21(3):167-70. PubMed ID: 7794495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal antibiotic sensitivity testing: use of Autobac 1 for standardization purposes.
    Seguela JP; Lepargneur JP; Saveres C; Cazaux M; Riser A; Linas MD
    Mycopathologia; 1980 Aug; 72(1):13-9. PubMed ID: 7421978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G; Manzara S; Dettori G
    Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of in vitro activities of amphotericin, clotrimazole, econazole, miconazole, and nystatin against Fusarium oxysporum.
    Tzatzarakis MN; Tsatsakis AM; Charvalos E; Vakalounakis D
    J Environ Sci Health B; 2001 May; 36(3):331-40. PubMed ID: 11411855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental evaluation of antifungal and antiseptic agents against Rhodotorula spp.
    Preney L; Théraud M; Guiguen C; Gangneux JP
    Mycoses; 2003 Dec; 46(11-12):492-5. PubMed ID: 14641623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antifungal susceptibility of emerging yeast pathogens].
    García-Martos P; Domínguez I; Marín P; García-Agudo R; Aoufi S; Mira J
    Enferm Infecc Microbiol Clin; 2001; 19(6):249-56. PubMed ID: 11440661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disk agar diffusion susceptibility testing of yeasts.
    Saubolle MA; Hoeprich PD
    Antimicrob Agents Chemother; 1978 Oct; 14(4):517-30. PubMed ID: 568910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative sensitivity of yeasts to antifungal agents using a standardized micromethod].
    Guinet R
    Pathol Biol (Paris); 1986 May; 34(5):536-9. PubMed ID: 3534739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of Trichosporon beigelii to antifungal agents.
    Perparim K; Nagai H; Hashimoto A; Goto Y; Tashiro T; Nasu M
    J Chemother; 1996 Dec; 8(6):445-8. PubMed ID: 8981185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimycotic sensitivity of yeast from clinical specimens (author's transl)].
    Baier R; Puppel H
    Dtsch Med Wochenschr; 1978 Jul; 103(27):1112-6. PubMed ID: 307486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
    Paniagua GL; Monroy E; Negrete E; Vaca S
    Rev Latinoam Microbiol; 2002; 44(2):65-8. PubMed ID: 17063773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC.
    Fromtling RA; Abruzzo GK; Bulmer GS
    Mycopathologia; 1986 Apr; 94(1):27-30. PubMed ID: 3014339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of amphotericin B, flucytosine and fluconazole against yeasts causing bloodstream infections.
    Berenguer J; Fernández-Baca V; Sánchez R; Bouza E
    Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):362-5. PubMed ID: 7649205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of Candida albicans isolates from apical and marginal periodontitis to common antifungal agents.
    Waltimo TM; Ørstavik D; Meurman JH; Samaranayake LP; Haapasalo MP
    Oral Microbiol Immunol; 2000 Aug; 15(4):245-8. PubMed ID: 11154410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The postantibiotic effect of antifungal agents against common pathogenic yeasts.
    Turnidge JD; Gudmundsson S; Vogelman B; Craig WA
    J Antimicrob Chemother; 1994 Jul; 34(1):83-92. PubMed ID: 7961219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans.
    Gudewicz TM; Mader JT; Davis CP
    Aviat Space Environ Med; 1987 Jul; 58(7):673-8. PubMed ID: 3304267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.